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AbstrACt
Objectives Prevalence of multimorbidity has been 
increasing worldwide. While population ageing 
undoubtedly contributes, secular trends have seldom 
been decomposed into age, period and cohort effects 
to investigate intergenerational differences. This study 
examines the birth cohort effect on morbidity burden and 
multimorbidity in Hong Kong community.
Design Sex-specific age-period-cohort analysis with 
repeated cross-sectional surveys.
setting A territory-wide population survey database.
Participants 69 636 adults aged 35 or above who 
participated in the surveys in 1999, 2001, 2005 or 2008.
Main outcome measures Morbidity burden was 
operationalised as number of chronic conditions from 
a list of 14, while multimorbidity was defined as a 
dichotomous status of whether participants had two or 
more conditions.
results For both sexes, there was an upward inflection 
(positive change) of risk of increased morbidity burden 
starting from cohort 1955–1959. For men born after 
1945–1954, there was a trend of lower risk (relative 
risk=0.63, 95% CI 0.50 to 0.80 for 1950–1954 vs 
1935–1939) which continued through subsequent cohorts 
but with no further declines. In women, there had been 
a gradual increase of risk, although only significant for 
cohort 1970–1974 (relative risk=1.90, 95% CI 1.08 
to 1.34 vs 1935–1939). Similar results were found for 
dichotomous multimorbidity status.
Conclusions The trend of lower risk starting from men 
born in 1945–1954 may be due to a persistent decline 
in smoking rates since the 1980s. On the other hand, the 
childhood obesity epidemic starting from the late 1950s 
coincided with the observed upward inflection of risk for 
both sexes, that is, notably more drastic increase of risk 
in women and the levelling-off of the decline of risk in 
men. These findings highlight that the cohort effects on 
morbidity burden and multimorbidity may be sex-specific 
and contextual. By examining such effects in different 
world populations, localised sex-specific and generation-
specific risk factors can be identified to inform policy-
making.
IntrODuCtIOn 
Multimorbidity, defined as the co-occurrence 
of two or more chronic health conditions 
in an individual,1 is increasingly common as 
populations age.2–5 It is consistently found 
to be associated with poorer quality of life,6 
greater healthcare utilisation,7 and greater 
risk of mortality.8 This problem is also char-
acterised by a steep socioeconomic gradient 
whereby prevalence is significantly higher 
among socioeconomically deprived popu-
lations.9 10 However, since secular trends of 
multimorbidity are seldom decomposed into 
separate temporal dimensions (biological 
age, calendar period and birth cohort11), it is 
largely unclear whether the increasing prev-
alence is solely driven by population ageing, 
or whether it also reflects changing risk in 
different birth cohorts.
In the study of temporal trends, intergener-
ational/cohort differences of disease frequen-
cies have often been neglected with more 
focus on the effects of age and period, which 
represent, respectively, the biological ageing 
strengths and limitations of this study
 ► We adopted population-based survey data which 
are highly representative of the Hong Kong commu-
nity-dwelling population.
 ► Sampling strategy and data collection methodol-
ogy were highly consistent across years, that is, 
1999–2008.
 ► We did not analyse institutionalised people who 
may have a significantly higher prevalence of 
multimorbidity.
 ► There may be self-report bias in the measure of 
morbidity burden and multimorbidity status.
 ► Repeated cross-sectional nature of the data renders 
causal inferences inappropriate.
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processes and the environmental factors happening at 
the time of data collection (eg, diagnosis). Birth cohort 
membership, on the other hand, represents the health-re-
lated exposures of the same generations; for instance, 
similar nutrition and consumption patterns, similar living 
environments such as housing types and similar quality 
of healthcare and other services during early life.11 12 The 
comparison of cohorts, therefore, may reveal intergener-
ational differences of these exposures in relation to the 
trend of multimorbidity. Nonetheless, without proper 
statistical adjustments, risk differences across cohorts 
assuming the same age and period cannot be properly 
observed, and thus, the underlying factors of genera-
tion-specific risks that may potentially inform healthcare 
policies remain largely unknown. Existing literature on 
birth cohort effects on multimorbidity is also scarce, and 
the only identified study that investigated cohort effects 
on multimorbidity in Canada included a limited span of 
birth years that were grouped into five 10 year cohorts 
only.13 Moreover, cohort effects depend on a wide range 
of population-specific factors.14–16 Further research in 
different populations is therefore warranted to inform 
localised generation-specific policies and to predict 
the health status of the ‘in-coming’ older people who 
currently belong to younger cohorts.
This study examines the birth cohort effect on 
increased morbidity burden and multimorbidity in Hong 
Kong. Like the rest of the developed world, the city has 
a progressively ageing population, with the median age 
rising from 36.7 in 2001 to 43.4 in 2016.17 18 In addition, 
the life experience across generations in Hong Kong 
has changed very rapidly during the past decades, which 
may be conducive to intergenerational differences in 
the prevalence of multimorbidity. Hong Kong experi-
enced several waves of massive migration from Mainland 
China during the mid-1900s due to the World War II, the 
Chinese Civil War and the postwar political turmoil.19 
These healthy immigrants and their descendants consti-
tute the vast majority of the modern population of Hong 
Kong.19 During the post-war period, Hong Kong was one 
of the fastest growing economies in the world, achieving 
an annual growth rate of 9.5% from 1961 to 1982,20 
and experienced very rapid macroenvironmental socio-
economic transitions. These transitions have, in turn, 
resulted in multiple large changes in society, including 
substantial improvements in living standards, healthcare 
services, health literacy and public hygiene.
Based on the findings from previous studies in Hong 
Kong that identified significant cohort effects (ie, inter-
generational differences) in other population health 
indicators, most notably all-cause and cause-specific 
mortality,14 21–25 we hypothesise a similar significant 
role of the birth cohort in determining the prevalence 
of morbidity burden and multimorbidity. Owing to the 
substantial differences between men and women in physi-
ology and lifestyle as well as the rapid changes to the role 
of women in society, we further stratified the analyses by 
sex.
MethODs
study population
The Thematic Household Survey (THS) on health-related 
topics conducted by the Government in 1999, 2001, 2005 
and 2008 supplied the data for this study. By geographi-
cally stratified random sampling, each of the four rounds 
of survey covered 95% of the non-institutionalised resi-
dential population in Hong Kong (106 332 respondents 
aged 15 years or older) and collected cross-sectional 
self-reported data on chronic health conditions, health-
care utilisation and sociodemographic characteristics. In 
this study, we only included adults aged 35 years or older 
(n=69 636) since we primarily focused on non-communi-
cable diseases. The publicly available online THS reports 
give more detailed descriptions of the sampling and 
data collection procedures.26 During the period 1999–
2008, there have been no major changes in the institu-
tionalised population with annual number of hospital 
admissions remaining steadily at around 1.2 million and 
a discharge rate of around 160 per 1000 persons.27 Also, 
the percentage of older persons living in elderly care 
homes was estimated at around 1.7% over the period.28 
Since this study only involves the analysis of anonymous 
secondary data, no ethical approval was required.
Patient and public involvement
The study did not involve patients. The survey data are 
available on request from the Food and Health Bureau 
of the Hong Kong SAR Government, a third party, to 
researchers who meet the criteria for access to confiden-
tial data.
Measures
Morbidity burden and multimorbidity
THS collected participants’ self-report of whether they 
had been told by a medical doctor that they had any of 
the following 14 diseases: hypertension, high cholesterol, 
diabetes, heart disease, thyroid disease, liver disease, 
chronic bronchitis/emphysema/ bronchiectasis, asthma, 
chronic kidney disease, stroke, anaemia, skin disease, 
malignant neoplasm and immune disease. The primary 
study outcome was morbidity burden, defined as the 
count of how many of the 14 chronic diseases each indi-
vidual had. Multimorbidity status, defined as an indi-
vidual having two or more chronic diseases, was used as 
the secondary outcome.
Age, period and cohort effects
We used self-reported age (in years) to represent the 
temporal dimension of biological age, and used the 
4 years of survey, that is, 1999, 2001, 2005 and 2008, 
to represent the calendar periods. The birth year was 
derived by subtracting the individuals’ age from the 
year of survey and grouped into 15 5-year birth cohorts 
ranging from 1900 to 1904 to 1970–1974. In our study, 
the age effect represents the average change in the risk 
of increased morbidity burden and multimorbidity when 
a person advances in age, regardless of the year he/she 
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was born or the time he/she was surveyed. The period 
effect represents the variation in the risk across time (ie, 
different years of survey in this case), given the same age 
and birth cohort. Finally, the cohort effect represents the 
effect of being born in particular years compared with 
other years on the risk of increased morbidity burden and 
multimorbidity, with age and year of survey held constant.
Analysis
Hierarchical age-period-cohort analyses
To address the problem of collinearity between age, 
period and cohort (Period-age=cohort) in estimating rela-
tive risks, we adopted the hierarchical age-period-cohort 
modelling approach proposed by Yang and Land.25 29 We 
constructed a series of generalised linear mixed models 
(Poisson regression) with the number of chronic diseases 
(ordinal, out of the listed 14) as the primary outcome 
to decompose the secular trends into age, period and 
cohort effects. We then conducted similar analyses 
(logistic regression) for multimorbidity status (binary) as 
the secondary outcome.
Since the effect of the biological ageing process should 
be relatively universal across individuals, we specified age 
effect as fixed. The cohort effect was also specified as 
fixed because of the uniqueness of the lifetime health-re-
lated exposures to each birth cohort, which would not be 
appropriately represented by a random effect assumed to 
be normally distributed.30 We specified the period effects 
to be random because there is no reason to believe that 
any of the 4 years of survey have had a unique effect on 
multimorbidity. The Hausman specification test was also 
conducted to confirm the appropriateness of this model 
specification. We conducted an overall analysis with statis-
tical adjustment for sex, followed by a sex-specific anal-
ysis. The Poisson model was formally written as follows:
  ln
(
E
(
yijk
))
= β0jk + β1Ageijk + β2Age
2
ijk  
 
 
β0jk = γ0 + γ1j
J∑
j=2
Cohortj + v0k
 
 
  v0k ∼ N
(
0, τv
)
  
where the expected number of chronic diseases  yijk  in 
individual i born in cohort j surveyed in year k was explained 
in a two-level random intercept model.  v0k  represents the 
residual random effect of year k assumed to be following 
a normal distribution with mean 0 and variance  τv .  γ0  is 
the model intercept.  γ1  represents the fixed effect of 
cohort j. J is the number of cohorts. Subsequently, we 
replicated these procedures using multimorbidity status 
as a secondary analysis (logistic regression). Relative risks 
and ORs were plotted and tabulated to observe the inter-
generational trends.
sensitivity analyses
A series of sensitivity analyses was conducted. First, to 
investigate the possible role of changing lifestyle patterns, 
we replicated the main analyses with the count of mainly 
lifestyle-related diseases (ie, hypertension, high choles-
terol, diabetes, heart disease, chronic kidney disease, 
stroke, malignant neoplasm) as the outcome. Second, 
we replicated the analyses with the period effect speci-
fied as fixed to examine how results might change with 
a different model specification. Third, we adopted the 
leave-one-out approach where we replicated the primary 
analyses by omitting one of the 14 listed diseases in each 
replication. Last, since hypertension and high cholesterol 
were the main drivers of the increase in the prevalence of 
multimorbidity, we conducted a further replication with 
those two conditions omitted.
There were no missing data in the study since only 
information on age, sex, survey year and presence of 
self-report chronic diseases (with absence of self-reports 
being treated as non-case) were needed for the analyses. 
We conducted all the analyses in the R statistical envi-
ronment (V.3.3.3), and implemented generalised linear 
mixed models using the R package ‘lme4’.31
results
sample characteristics
Table 1 shows the sample characteristics by the year of 
survey. An alternative tabulation of the information 
by sex is presented as online supplementary table ST1. 
Across the years of survey, the sex ratio was reasonably 
balanced. The ageing of the Hong Kong population over 
the period is apparent from the changing age composi-
tion of the sample: 14.0% participants were aged 70 years 
or older in 1999 compared with 17.1% in 2008. Except 
for thyroid disease, an increase is observed in the propor-
tion of participants reporting a diagnosis for all the listed 
diseases. In 1999, 3.5% of the participants were classified 
as multimorbid (reporting two or more diseases), while 
the figure increased to 8.8% in 2008. Figure 1 shows the 
proportion of multimorbid participants by age and sex 
across the years of survey.
Age-period-cohort analyses
Hausman specification test results confirmed the appro-
priateness of specifying fixed cohort effects and random 
period effects (online supplementary table ST2). Relative 
risk estimates were consistently lower in earlier cohorts 
born in the first half of the 20th century than in the 
reference 1935–1939 cohort in all three models (overall, 
male and female, figures 2 and 3), possibly due to healthy 
survivor effect in that the very old people who lived long 
enough to be surveyed may be healthier. Nevertheless, 
the relative risks were non-significant, possibly because 
of smaller numbers of older people surveyed. The 
age effects (fixed) in the analyses all showed a general 
increase of risk with increased age but with a slight decline 
at an advanced age (as illustrated by relative risks for the 
squared standardised age <1) possibly due to a healthy 
survivor effect.
Overall model
In the overall analysis (men and women combined) as 
shown in figure 2 and online supplementary table ST3, 
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Table 1 Sample characteristics by year of survey*
Year of survey 1999 2001 2005 2008 Total
N 17 229 17 700 17 311 17 396 69 636
Sex (%)
  Male 8533 (49.5) 8640 (48.8) 8441 (48.8) 8432 (48.5) 34 046 (48.9)
  Female 8696 (50.5) 9060 (51.2) 8870 (51.2) 8964 (51.5) 35 590 (51.1)
Age (%)
  35–39 3375 (19.6) 3081 (17.4) 2432 (14.0) 2214 (12.7) 11 102 (15.9)
  40–44 3309 (19.2) 3391 (19.2) 2854 (16.5) 2531 (14.5) 12 085 (17.4)
  45–49 2441 (14.2) 2571 (14.5) 2842 (16.4) 2730 (15.7) 10 584 (15.2)
  50–54 1979 (11.5) 2285 (12.9) 2504 (14.5) 2595 (14.9) 9363 (13.4)
  55–59 1155 (6.7) 1252 (7.1) 1749 (10.1) 1899 (10.9) 6055 (8.7)
  60–64 1359 (7.9) 1241 (7.0) 1190 (6.9) 1385 (8.0) 5175 (7.4)
  65–69 1199 (7.0) 1316 (7.4) 1101 (6.4) 1064 (6.1) 4680 (6.7)
  70–74 1080 (6.3) 1206 (6.8) 1064 (6.1) 1163 (6.7) 4513 (6.5)
  75–79 636 (3.7) 700 (4.0) 780 (4.5) 819 (4.7) 2935 (4.2)
  80–84 451 (2.6) 413 (2.3) 498 (2.9) 651 (3.7) 2013 (2.9)
  85–89 182 (1.1) 171 (1.0) 211 (1.2) 231 (1.3) 795 (1.1)
  90–94 53 (0.3) 60 (0.3) 65 (0.4) 94 (0.5) 272 (0.4)
  95–99 10 (0.1) 12 (0.1) 21 (0.1) 19 (0.1) 62 (0.1)
  100+ 0 (0.0) 1 (0.0) 0 (0.0) 1 (0.0) 2 (0.0)
Birth cohort (%)
  1900–1904 10 (0.1) 4 (0.0) 0 (0.0) 0 (0.0) 14 (0.0)
  1905–1909 53 (0.3) 32 (0.2) 8 (0.0) 2 (0.0) 95 (0.1)
  1910–1914 182 (1.1) 101 (0.6) 45 (0.3) 25 (0.1) 353 (0.5)
  1915–1919 451 (2.6) 301 (1.7) 164 (0.9) 116 (0.7) 1032 (1.5)
  1920–1924 636 (3.7) 568 (3.2) 395 (2.3) 279 (1.6) 1878 (2.7)
  1925–1929 1080 (6.3) 987 (5.6) 711 (4.1) 674 (3.9) 3452 (5.0)
  1930–1934 1199 (7.0) 1276 (7.2) 978 (5.6) 886 (5.1) 4339 (6.2)
  1935–1939 1359 (7.9) 1290 (7.3) 1087 (6.3) 1149 (6.6) 4885 (7.0)
  1940–1944 1155 (6.7) 1152 (6.5) 1084 (6.3) 1083 (6.2) 4474 (6.4)
  1945–1949 1979 (11.5) 1779 (10.1) 1691 (9.8) 1491 (8.6) 6940 (10.0)
  1950–1954 2441 (14.2) 2507 (14.2) 2141 (12.4) 2025 (11.6) 9114 (13.1)
  1955–1959 3309 (19.2) 3128 (17.7) 2993 (17.3) 2643 (15.2) 12 073 (17.3)
  1960–1964 3375 (19.6) 3279 (18.5) 2657 (15.3) 2709 (15.6) 12 020 (17.3)
  1965–1969 0 (0.0) 1296 (7.3) 2789 (16.1) 2436 (14.0) 6521 (9.4)
  1970–1974 0 (0.0) 0 (0.0) 568 (3.3) 1878 (10.8) 2446 (3.5)
Self-reported chronic diseases (%)
  Hypertension 1337 (7.8) 1567 (8.9) 2304 (13.3) 2839 (16.3) 8047 (11.6)
  High cholesterol 142 (0.8) 143 (0.8) 313 (1.8) 1027 (5.9) 1625 (2.3)
  Diabetes 712 (4.1) 841 (4.8) 925 (5.3) 1173 (6.7) 3651 (5.2)
  Heart disease 440 (2.6) 528 (3.0) 537 (3.1) 503 (2.9) 2008 (2.9)
  Thyroid disease 129 (0.7) 128 (0.7) 142 (0.8) 127 (0.7) 526 (0.8)
  Liver disease 66 (0.4) 80 (0.5) 110 (0.6) 132 (0.8) 388 (0.6)
  Chronic bronchitis/emphysema/
bronchiectasis 99 (0.6) 160 (0.9) 124 (0.7) 144 (0.8) 527 (0.8)
  Asthma 112 (0.7) 131 (0.7) 151 (0.9) 190 (1.1) 584 (0.8)
Continued
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there was a substantial decline in the relative risk of an 
additional morbidity compared with the 1935–1939 
cohort from 0.96 (0.89 to 1.04) for the 1940–1944 cohort 
to 0.79 (0.67 to 0.93) for the 1950–1954 cohort with a 
subsequent flattening. Women were estimated to have a 
13% elevated risk (RR=1.13, 1.10 to 1.16) of having an 
additional chronic disease compared with men.
sex-specific models
In the analysis of men as also shown in figure 3 and 
online supplementary table ST3, there was a significant 
decline of risk from cohort 1940–1944 (RR=0.96, 0.86 to 
1.07) to cohort 1945–1949 (RR=0.82, 0.69 to 0.97) but 
without further apparent changes in later cohorts (ie, a 
levelling-off of the decline in the 1950s). In women, the 
estimated relative risk increased from 0.20 (0.03 to 1.37) 
in cohort 1905–1909 to 1.90 (1.08 to 3.34) in cohort 
1970–1974, without any significant difference of the 
risk between neighbouring cohorts, but a more drastic 
increase was observed after those born in 1955–1959. 
Based on the sex-specific models, we also predicted the 
average number of chronic diseases assuming an age of 
50 years and in period 2008 to facilitate interpretation of 
the cohort effects, and we visualised our results in online 
supplementary figure SF1. Furthermore, our secondary 
analysis using binary classification of multimorbidity 
status as the outcome shows no essential difference in the 
results (online supplementary table ST4).
sensitivity analyses
The replication of the main analyses with number of life-
style-related diseases as the study outcome yielded essen-
tially the same results: a decline of risk from cohorts born 
in 1940–1944 to those in 1950–1954 in the overall anal-
ysis and in men; and an increase of risk in women from 
cohort 1905–1909 to cohort 1970–1974 (online supple-
mentary table ST5). The alternative model with period 
effects specified as fixed (online supplementary table 
ST6) showed no apparent differences in cohort effects 
from the main analyses, but it showed an increased period 
effect from 1999 to 2008. Finally, the replications of anal-
yses with certain diseases omitted showed no substantial 
differences from the primary findings either (online 
supplementary tables ST7–8).
The results of these sensitivity analyses support the 
robustness of the main findings because results did not 
differ significantly for different model specifications, 
different selections of included diseases, and whether 
only lifestyle-related diseases were considered in defining 
multimorbidity.
DIsCussIOn
summary of findings
The analyses confirmed the hypothesised sex-specific 
role of the birth cohort effect in the determination of the 
risk of morbidity burden and multimorbidity. There were 
notable differences in the cohort effects between men 
and women. Specifically, there was an obvious decline 
in the risk of having increased morbidity burden and of 
having multimorbidity in men born between 1945 and 
1954 compared with the preceding cohorts, and this 
reduction was sustained but did not further increase in 
later cohorts (the 1950s and after). In contrast, there 
was a steady increase in estimated relative risk in women 
from cohort 1905–1909 to cohort 1970–1974, with more 
apparent increase after the late 1950s cohort; however, 
none of these were statistically significant except the rela-
tive risk of the latest cohort 1970–1974.
Interpretations
This study extends and complements previous research on 
the secular trends of morbidity burden and multimorbidity 
Year of survey 1999 2001 2005 2008 Total
  Chronic kidney disease 55 (0.3) 97 (0.5) 75 (0.4) 74 (0.4) 301 (0.4)
  Stroke 94 (0.5) 128 (0.7) 118 (0.7) 194 (1.1) 534 (0.8)
  Anaemia 13 (0.1) 19 (0.1) 34 (0.2) 57 (0.3) 123 (0.2)
  Skin disease 92 (0.5) 88 (0.5) 90 (0.5) 198 (1.1) 468 (0.7)
  Malignant neoplasm 139 (0.8) 142 (0.8) 159 (0.9) 169 (1.0) 609 (0.9)
  Immune disease 6 (0.0) 18 (0.1) 45 (0.3) 56 (0.3) 125 (0.2)
Number of chronic diseases (%)
  None 14 523 (84.3) 14 549 (82.2) 13 420 (77.5) 12 517 (72.0) 55 009 (79.0)
  One 2102 (12.2) 2412 (13.6) 2872 (16.6) 3343 (19.2) 10 729 (15.4)
  Two 495 (2.9) 593 (3.4) 837 (4.8) 1163 (6.7) 3088 (4.4)
  Three 96 (0.6) 120 (0.7) 150 (0.9) 298 (1.7) 664 (1.0)
  Four 10 (0.1) 20 (0.1) 29 (0.2) 59 (0.3) 118 (0.2)
  Five or more 3 (0.0) 6 (0.0) 3 (0.0) 16 (0.1) 28 (0.0)
*Percentage reported in brackets, which may not add up to 100% due to rounding.
Table 1 Continued 
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by further decomposing temporal trends into dimensions 
of age, period and cohort in the population of Hong 
Kong.2–4 As far as we know, this is the first study in Asia to 
investigate the potential role of the birth cohort in deter-
mining changing morbidity burden and multimorbidity. 
A recent Canadian study is the only one we know of which 
tested the cohort effects on multimorbidity, finding a 
monotonic increase in the risk of multimorbidity in 
each of the successive 10 year cohorts (1925–1974). The 
Canadian study did not report differing cohort effects by 
sex, while our findings suggest that the cohort effects on 
morbidity burden and multimorbidity in Hong Kong are 
highly sex-specific, suggesting the potential differences in 
the role of intergenerational effects on health between 
the two populations.13
The Canadian study attributed the increase in multi-
morbidity over time to an increasing prevalence of obesity 
in the population.32 This is a plausible explanation for 
part of the cohort effects observed in both sexes in this 
study and is consistent with the observation described 
in a previous study in Hong Kong.8 Hong Kong experi-
enced a growth in infant and childhood obesity starting 
from around the late 1950s33–35 which coincided with 
the upward inflection (positive second-order change of 
slope) of morbidity burden and multimorbidity for the 
late 1950s to early 1960s cohorts for both sexes in this 
study, namely, the levelling off of the decline of risk in men 
and a more drastic increase of risk in women. This cohort 
effect may imply that infancy and early childhood are 
probably critical periods when early life exposure affects 
Figure 1 Proportion of multimorbid participants by age and sex across the years of survey.
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later risks of morbidity, or that there may be cumulative 
impact of lifetime obesity starting in early life that drives 
risk of morbidity. This is also consistent with the literature 
that childhood obesity affects later adult health risk, espe-
cially in cardiovascular and metabolic diseases.36 37
A potential explanation for the substantial decline of 
risk in men born in the late 1940s and the early 1950s is 
the drastic drop in the smoking rate in the early 1980s 
and the continued decline thereafter.38 The subanalysis 
of lifestyle-related morbidity burden also supported this 
speculation since the similar decline of risk from cohorts 
born in 1940–1944 to those in 1950–1954 was even more 
drastic than in the primary analysis and continued to be 
statistically significant in younger cohorts. Towards the 
late 1970s, the evidence of the adverse health effects 
of smoking became widely recognised internationally 
and locally. In 1982, the Smoking (Public Health) Ordi-
nance was enacted in Hong Kong.39 It was documented 
that during the 2 years after the enactment, there was a 
16% reduction in the number of smokers.39 The reason 
we believe this change has had a much stronger effect in 
men than in women is that 88.5% of smokers in 1982 and 
85.3% of the 143 800 quitters in the following 2 years were 
men.39 These men probably enjoyed the health benefits 
of smoking cessation at a relatively younger age, especially 
those born in or after the 1940s.40 41 These large changes 
in smoking are known to be associated with particularly 
rapid declines in lung cancer mortality in the cohorts 
born in the late 1940s and the early 1950s.14 Although 
the Canadian population saw a decline in total smoking 
rate from 32.0% in 1975 to 26.6% in 1986,42 it is not as 
dramatic as in Hong Kong where, by 2015, the average 
daily smoking rate was only 10.5%.38
Women, in contrast, experienced slowly increasing risk 
of increased morbidity burden in successive birth cohorts 
although only statistically significantly increased in the 
final 1970–1974 cohort. There is no clear explanation for 
this, although enhanced health awareness and a better 
diagnosis of asymptomatic conditions may contribute, 
facilitated by better education of women of later gener-
ations in Hong Kong. The British colonial government 
Figure 2 Age-adjusted and sex-adjusted relative risks of 
an additional self-reported chronic disease in an individual 
by birth cohorts Hong Kong. Cohort 1935–1939 serves as 
the referent cohort. Bars represent the 95% CI of the relative 
risks.
Figure 3 Sex-specific age-adjusted relative risks of an additional self-reported chronic disease in an individual by birth cohorts 
in Hong Kong. Cohort 1935–1939 serves as the referent cohort. Bars represent the 95% CI of the relative risks. Triangles 
represent men and rhombi represent women.
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introduced a policy of free and compulsory 6 year educa-
tion (primary schooling) in 1971, and 9-year education 
(primary and junior secondary schooling) in 1978 which 
enabled many girls who would have gone to work to 
attend school instead. From 2001 to 2011, the propor-
tion of women aged 45 or older who had completed 
secondary education increased from 28.3% to 45.9%.17 43 
Better access to the healthcare services for women across 
generations, due to better education and improvements 
in services may explain increases in diagnosed morbidity. 
Other research has shown a decline in the risk of death 
from chronic diseases in women across generations in 
Hong Kong,14 consistent with increasing diagnosis and 
active management of conditions like hypertension.
Over the period of 1999–2008, except for a voluntary 
cervical screening programme for women introduced in 
March 2004,44 no territory-wide screening programmes 
for the general population have been launched and no 
major changes in healthcare policies were introduced.45 
The increasing trend of morbidity burden across periods 
observed in online supplementary table ST6 may reflect 
an actual increase of morbidity burden and/or, like 
our speculations on the cohort effects in women, be 
attributed to a heightened health awareness and better 
access to healthcare services among the city’s population. 
Future research which covers a longer study period may 
be conducted for a more focused examination of the 
period effects.
Public health implications
The findings of this study enable us to project the possible 
trend of the healthcare burden associated with the younger 
cohorts as they age. Specifically, we may anticipate a rela-
tively lower risk of morbidity in the younger cohorts of 
men who will all become part of the older population by 
year 2020 (ie, starting from those born in the late 1940s 
and the early 1950s) than the current older men (ie, born 
before the late 1940s). Since the lack of further decline 
of the risk of morbidity burden among men born after 
the late 1950s may be explained by increasing childhood 
obesity as discussed above, the Government may consider 
further promoting physical exercise and healthy diets 
and lifestyle among the younger cohorts to further mini-
mise the risk of morbidity burden and multimorbidity. 
On the other hand, we expect a greater likelihood of 
women of the younger cohorts to be identified as having 
increased morbidity burden and multimorbidity than 
the current older women, possibly due to the childhood 
obesity problem in the late 1950s and increased diag-
nosis in younger generations due to altered help-seeking 
behaviour and access to health services. However, since 
almost all relative risks for women are not statistically 
significant, we should be cautious with our interpreta-
tions. But if this is the case, the Government may accord-
ingly consider increasing the capacity and resources of 
the healthcare system to cope with the rising demand for 
treating chronic diseases, which might further increase 
among the in-coming older women. On the flip side, 
increasing disease rates in women due to the enhance-
ment of health awareness might not necessarily be a bad 
thing because if treated, they will reduce morbidity and 
subsequently mortality down the line. Following this 
argument, this then begs the question whether the lack 
of increase of morbidity burden risk in men suggests that 
it is rather the men who are being underdiagnosed. Given 
that men do not seek help as often as women, better 
disease screening and promotion of health awareness 
may be warranted.
limitations
Despite the data being population-representative, there 
are several limitations. First, the presence of chronic 
diseases was self-reported, and there may be recall bias 
(most likely recalling fewer diseases) especially among 
older people, the risk in whom could thus be underes-
timated. However, in population surveys where a large 
sample is collected, it is usually not feasible to require 
formal documentation of diagnosis. Second, the compre-
hensiveness of the list of chronic diseases is limited by 
data availability across surveys. The observed sex-specific 
patterns may depend on the selection of diseases and may 
not be identical when another list is used. For example, 
it is known that prevalence of musculoskeletal diseases 
varies significantly by sex.46 Although this list is far from 
exhaustive, a previous systematic review has shown that 
estimated prevalence of multimorbidity varies relatively 
little for studies having 12 or more conditions.47 Our 
list also overlapped with those adopted in many other 
previous studies.48 Third, since the THS only covered 
the non-institutionalised residential population of Hong 
Kong, hospitalised patients or older people in residen-
tial care homes, who were likely to have more chronic 
diseases, were not included in this study. Fourth, as the 
dataset is formed by repeated cross-sectional surveys, 
within-subject changes could not be investigated. Fifth, 
we did not apply weighting to our analyses in this study 
mainly because of the limitations of survey weightings in 
multivariable analyses, namely the contested approaches 
to weighting regression coefficients, difficulties in evalu-
ating SEs for the weighted regression coefficients and the 
inevitable arbitrary choice of factors to be considered for 
the weighting.49 As a representative stratified sampling 
frame have been consistently adopted across the series of 
the population survey, the unweighted results should be 
sufficiently generalisable. Sixth, we did not consider the 
various socioeconomic, lifestyle and healthcare access-re-
lated factors at the individual level which may explain 
part of the intergenerational differences. However, the 
objective of an age-period-cohort modelling is to identify 
time-dependent effects of age, period and cohort, from 
which macroenvironmental risk factors can be identified. 
Therefore, if we adjust the aforementioned individu-
al-level factors in the age-period-cohort model, we may 
attenuate part of the total time-dependent effects of age, 
period and cohort which are in fact the main interest of 
this study. Although these individual-level factors are a 
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very promising direction for future research, we decided 
not to investigate them at this stage. Last, the period 
effect was limited by a short span of 10 years with only 
four period levels which may render part of the results 
of the mixed effects models less reliable. However, we 
replicated the analysis with period effects specified as 
fixed and obtained very similar birth cohort effects. The 
inclusion of period effects may serve as a multivariable 
adjustment which should have effectively addressed the 
change of diagnostic practice over the ten-year period 
when interpreting the estimated cohort effects. Future 
researchers with adequate accumulated data that cover 
a longer period of surveys should examine the period 
effect in more depth.
COnClusIOn
While ageing is a prevalent trend in all developed coun-
tries, cohort effects may be sex-specific and contextual. By 
delineating the cohort effects on morbidity burden and 
multimorbidity across generations, specific risk factors 
can be identified to inform localised policy-making. 
Other countries may also refer to our findings that point 
to the possible impact of reduction in smoking rates on 
the decreased risk as well as the possible impact of child-
hood obesity on the increased risk of morbidity burden 
and multimorbidity. Further cohort studies are warranted 
to investigate these associations.
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